Details for 2004768997

Up to date per 13.05.2026

Actions

Title / Product Name

VERFAHREN ZUR HERSTELLUNG DES CALCIUMSALZES VON ROSUVASTATIN-(E)-7-[4-(4-FLUORPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO] PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE- UND KRISTALLINEN ZWISCHENPRODUKTEN DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2004768997

EP Publication Number

1682536

E-Number

598465

Language

PCT Number

GB04004481

Publication Date

26.07.2006 A

27.02.2013 B1

Registration Date

27.02.2013

AT Publication Date

15.03.2013

Application Date

22.10.2004

Registration Number

Priorities

24.10.2003

0324791

IPC

C07D 405/06 20060101AFI20050519BHEP

Maximum Duration of Protection

22.10.2024

Owner

AstraZeneca UK Limited2 Kingdom Street London W2 6BDGB

SHIONOGI & CO., LTD.1-8, Doshomachi 3-chome, Chuo-ku Osaka 541-0045JP

Representative

No representatives present

Inventor

OKADA, Tetsuo, Shionogi & Company Limited12-4 Sagisu 5-chome Fukushima-ku, Osaka 553-002JP

HORBURY, John, AstraZenecaAvlon Works, Severn Road Hallen, Bristol BS10 7ZEGB

LAFFAN, David Dermot Patrick, AstraZenecaCharter Way Macclesfield, Cheshire SK10 2NAGB